Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Yu A Starchina"'
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 4, Iss 1, Pp 96-101 (2012)
The paper reviews the data available in the literature on the prevention of ischemic stroke by using antihypertensive therapy. It gives international guidelines and the results of randomized placebo-controlled trials of the use of different antihyper
Externí odkaz:
https://doaj.org/article/c20e6a8ac69242c6a3e9fa9512ca2ba4
Autor:
V A Parfenov, Yu A Starchina
Publikováno v:
Системные гипертензии, Vol 4, Iss 1, Pp 6-9 (2007)
Вероятность инсульта увеличивается более чем 10 раз у лиц, перенесших инсульт или транзиторную ишемическую атаку (ТИА), поэтому профилак
Externí odkaz:
https://doaj.org/article/974e73499072401f8002e67cbe9215e0
Autor:
I E Chazova, I P Kolos, V I Fedorova, T S Pustovitova, D V Ustyuzhanin, V E Sinitsyn, Yu A Starchina
Publikováno v:
Системные гипертензии, Vol 3, Iss 2, Pp 5-8 (2006)
В ряде работ установлена несомненная связь между уровнем систолического (САД), диастолического (ДАД) АД и риском развития острого наруше
Externí odkaz:
https://doaj.org/article/230ad00541b046d584946c5452284c0e
Publikováno v:
Neurology, Neuropsychiatry, Psychosomatics. 15:91-97
Cerebrovascular disease is one of the most common pathologies in the practice of a neurologist. Vascular cognitive impairment is the earliest and most objective sign of cerebrovascular pathology. The correction of vascular risk factors – antihypert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d3a8faf7c7fe1c6e28914c8a895cd5c
https://doi.org/10.14412/2074-2711-2023-2-91-97
https://doi.org/10.14412/2074-2711-2023-2-91-97
Autor:
Yu. A. Starchina, K. S. Sleptcova
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 13, Iss 5, Pp 90-95 (2021)
Cognitive impairment (CI) is one of the earliest and most frequent neurological disorders in patients with arterial hypertension. Arterial hypertension is a leading modifiable risk factor for stroke and cerebral microangiopathy, which underlies the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd879f28f62a775879e36c760ea10bba
https://doi.org/10.14412/2074-2711-2021-5-90-95
https://doi.org/10.14412/2074-2711-2021-5-90-95
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 13, Iss 3, Pp 119-124 (2021)
With an increase in life expectancy in the population, the proportion of people with cognitive impairment (CI) increases. Modern neurology focuses on the milder forms of CI: moderate, mild, and subjective CI, which are more promising in terms of succ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cde7df59cb4d4879bb349398b711fbf
https://doi.org/10.14412/2074-2711-2021-3-119-124
https://doi.org/10.14412/2074-2711-2021-3-119-124
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 13, Iss 1, Pp 113-118 (2021)
As the life expectancy of the population increases, cognitive impairment (CI) caused by cerebrovascular diseases is becoming an increasingly urgent problem. The leading role of hypertension in the development of CI of various origins has led to inten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470458040b479089c85ad504abd5a015
https://nnp.ima-press.net/nnp/article/view/1522
https://nnp.ima-press.net/nnp/article/view/1522
Autor:
N. V. Vakhnina, Yu. A. Starchina
Publikováno v:
Behavioral Neurology. :18-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecc478c4e6b0b45ce4cfb3cc15de32a6
https://doi.org/10.46393/2712-9675_2021_1_18-26
https://doi.org/10.46393/2712-9675_2021_1_18-26
Autor:
Yu. A. Starchina
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 11, Iss 3S, Pp 89-94 (2019)
Secondary prevention of recurrent stroke and other cardiovascular diseases is of key importance for the management of a patient after ischemic stroke. Medications (antihypertensive, antiplatelet, or anticoagulant drugs and statins) are recommended fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a53d9b2d435eadc0409aea11a744dd
https://doi.org/10.14412/2074-2711-2019-3s-89-94
https://doi.org/10.14412/2074-2711-2019-3s-89-94
Autor:
Vladimir V. Zakharov, Yu. A. Starchina
Publikováno v:
Effective Pharmacotherapy. 15:30-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eca87e058a90c8880fd3462a2ee9442
https://doi.org/10.33978/2307-3586-2019-15-19-30-37
https://doi.org/10.33978/2307-3586-2019-15-19-30-37